5.730USD+1.60%Mkt Cap: 22.62M $P/E: —1d ago
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure …
Industry Peers
Drug Manufacturers - Specialty & Generic$64.41BUSDP/E 23.3
$22.46BUSDP/E 19.5
$20.18BUSD
$17.25BUSDP/E 26.4
$15.40BUSDP/E 118.1
$14.51BUSDP/E 30.3
$12.90BUSD
$9.04BUSDP/E 23.0
$7.60BUSD
$6.84BUSDP/E 25.1
$6.69BUSDP/E 442.8
$5.70BUSDP/E 48.2
$3.69BUSDP/E 19.2
$3.57BUSDP/E 11.4
$3.01BUSDP/E 21.0
$2.80BUSD
$2.53BUSDP/E 56.2
$2.33BUSDP/E 16.1
$2.36BUSDP/E 12.8
$2.31BUSD
$1.90BUSDP/E 19.2
$1.89BUSD
$1.86BUSDP/E 21.0
$1.89BUSD
$1.57BUSD
$1.67BUSD
$1.48BUSDP/E 17.5
$1.50BUSDP/E 124.1
$1.40BUSDP/E 14.8
$1.21BUSDP/E 38.0
$1.18BUSDP/E 17.6
$1.20BUSD
$1.06BUSDP/E Infinity
$1.02BUSD
$1.01BUSDP/E 196.9
$985.07MUSD
$902.17MUSDP/E 14.5
$883.62MUSDP/E 38.6
$875.69MUSDP/E 12.0
$819.46MUSDP/E Infinity
$664.05MUSD
$692.84MUSDP/E 161.5
$637.05MUSDP/E 6.2
$503.88MUSDP/E 14.2
$494.34MUSD
$463.93MUSD
$427.80MUSD
$393.68MUSD
$375.56MUSD
$370.76MUSD
$355.90MUSD
$343.56MUSD
$319.75MUSDP/E 43.6
$351.79MUSD
$303.08MUSDP/E 9.7
$285.23MUSD
$267.31MUSDP/E 48.0
$280.94MUSDP/E 14.5
$250.29MUSDP/E 47.6
$255.34MUSDP/E 12.7
$233.72MUSDP/E 52.4
$207.94MUSDP/E 10.3
$210.49MUSD
$195.77MUSD
$185.67MUSD
$182.70MUSDP/E 8.8
$164.20MUSD
$143.51MUSDP/E 18.3
$146.07MUSD
$132.34MUSD
$126.10MUSD
$119.66MUSDP/E 18.6
$114.77MUSD
$85.39MUSDP/E 12.3
$94.75MUSD
$72.08MUSD
$65.22MUSD
$70.06MUSD
$63.45MUSDP/E 29.2
$60.45MUSDP/E 51.0
$63.41MUSD
$53.24MUSD
$52.01MUSD
$51.08MUSD
$49.45MUSD
$48.31MUSD
$41.74MUSD
$33.86MUSDP/E Infinity
$37.20MUSD
$31.62MUSD
$27.85MUSD
$26.87MUSD
$23.61MUSDP/E 204.0
$23.18MUSD
$22.15MUSD
$18.78MUSD
$17.65MUSD
$14.93MUSD
$13.64MUSDP/E 16.6
$14.21MUSD
$11.64MUSD
$11.91MUSD
$9.88MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.51MUSDP/E 4.0
$6.35MUSD
$6.48MUSDP/E 0.3
$5.84MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$1.93MUSD
$2.08MUSDP/E 35.5
$1.85MUSD
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap22.62M $
Enterprise Value13.12M $
Revenue (TTM)67.68M $
Gross Profit11.70M $
Net Income (TTM)-5.31M $
Revenue/Share18.14 USD
Last Price5.730 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees157
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS7743743004
Valuation
P/E (Trailing)—
P/E (Forward)81.86
PEG4.43
EV/EBITDA-4.96
EV/Revenue0.19
P/S0.33
P/B6.31
EPS (TTM)-1.50
EPS (Forward)0.07
52W Range
0.550093% of range6.140
52W High6.140 USD
52W Low0.5500 USD
Profitability
Gross Margin16.89%
Oper. Margin-8.54%
EBITDA Margin-3.91%
Profit Margin-7.67%
ROE-14.37%
ROA-9.30%
Growth
Revenue Growth-8.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-659.00K $
CapEx (TTM)542.00K $
FCF Margin0.75%
FCF Yield2.24%
Net Debt-9.50M $
Net Debt/EBITDA3.59
Balance Sheet
Debt/Equity0.34
Current Ratio3.74
Quick Ratio3.31
Book Value/Sh0.9080 USD
Cash/Share6.053 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 1, 2026
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)30.00 USD
Upside (mean)+423.6%
Target Range20.00 USD – 40.00 USD
$20.00+423.6% to mean$40.00
# Analysts2
Ownership
Shares Out.3.95M
Float3.51M
Insiders15.12%
Institutions10.08%
Short Interest
Short Ratio2.0d
Short % Float2.08%
Short % Out.2.04%
Shares Short80.33K
Short (prev mo.)38.40K
Technical
SMA 506.940 (-17.4%)
SMA 2009.190 (-37.7%)
Beta1.61
S&P 52W Chg20.25%
Avg Vol (30d)277.02K
Avg Vol (10d)43.26K
Technical Indicators
RSI (14)86.4
MACD1.3712
MACD Signal1.1174
MACD Hist.+0.2539
BB Upper8.290 USD
BB Middle3.145 USD
BB Lower-1.9998 USD
BB Width327.18%
ATR (14)0.3646 USD
Vol Ratio (20d)0.06x